SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-09-001154
Filing Date
2009-04-16
Accepted
2009-04-16 11:48:32
Documents
9
Period of Report
2009-05-13
Effectiveness Date
2009-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A w73474bdef14a.htm DEF 14A 381186
2 GRAPHIC w73474bw7347408.gif GRAPHIC 3496
3 GRAPHIC w73474bw7347400.gif GRAPHIC 1380
4 GRAPHIC w73474bw7347402.gif GRAPHIC 5319
5 GRAPHIC w73474bw7347401.gif GRAPHIC 3346
6 GRAPHIC w73474bw7347403.gif GRAPHIC 386
7 GRAPHIC w73474bw7347404.gif GRAPHIC 386
8 GRAPHIC w73474bw7347405.gif GRAPHIC 732
9 GRAPHIC w73474bw7347406.gif GRAPHIC 6206
  Complete submission text file 0000950133-09-001154.txt   413133
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 09753087
SIC: 2836 Biological Products, (No Diagnostic Substances)